Stockreport

Immunic shares gain on $400M raise to fund late-stage MS trials, commercial push [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Immunic shares gain on $400M raise to fund late-stage MS trials, commercial push [Read more]